Russian Health Ministry Authorises Clinical Trials of EpiVacCorona-N Vaccine

The Russian Health Ministry has authorized phase 1 and 2 clinical trials of EpiVacCorona-N, one more coronavirus vaccine developed by the Vector research center, accord

APD NEWS

APD NEWS

4 Years ago

Top trials volunteers virus viral virology vector vaccine tolerability